Relationship between kallikrein and PRA after intravenous furosemide. 1979

G A Cinotti, and G Stirati, and F Taggi, and R Ronci, and B M Simonetti, and A Pierucci

Interrelationships between plasma renin activity (PRA), urinary kallikrein and sodium excretion were studied before and after furosemide iv administration in nine normal volunteers and in one low renin non hypertensive patient. PRA, urinary kallikrein and sodium excretion increased within 15 min of furosemide injection in nine subjects; kallikrein excretion then decreased sharply, whereas plasma renin activity reached peak values within 15-120 min of stimulation. In low renin subject low basal levels of PRA paralled undetectable values of kallikrein excretion, and PRA and kallikrein excretion showed no increase after furosemide, despite the expected natriuretic response. The following conclusions appear feasible: (i) the natriuretic effect of fuorsemide is direct and independent of the effect on PRA and urinary kallikrein; (ii) in man, furosemide induces an increase in urinary kallikrein excretion which is immediate, of short duration and simultaneous in all the patient studied; (iii) no statistical correlation is demonstrated between the temporal behavior of urinary kallikrein and PRA; it is however possible that, at least for certain stimuli, renin release is in some way correlated with the activation of the renal kallikrein-bradykinin system.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D005260 Female Females
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23

Related Publications

G A Cinotti, and G Stirati, and F Taggi, and R Ronci, and B M Simonetti, and A Pierucci
April 1975, The Journal of physiology,
G A Cinotti, and G Stirati, and F Taggi, and R Ronci, and B M Simonetti, and A Pierucci
January 1990, Acta diabetologica latina,
G A Cinotti, and G Stirati, and F Taggi, and R Ronci, and B M Simonetti, and A Pierucci
January 1984, Urologia internationalis,
G A Cinotti, and G Stirati, and F Taggi, and R Ronci, and B M Simonetti, and A Pierucci
March 1982, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
G A Cinotti, and G Stirati, and F Taggi, and R Ronci, and B M Simonetti, and A Pierucci
December 1973, Agents and actions,
G A Cinotti, and G Stirati, and F Taggi, and R Ronci, and B M Simonetti, and A Pierucci
March 1987, Archives internationales de physiologie et de biochimie,
G A Cinotti, and G Stirati, and F Taggi, and R Ronci, and B M Simonetti, and A Pierucci
October 2001, Lancet (London, England),
G A Cinotti, and G Stirati, and F Taggi, and R Ronci, and B M Simonetti, and A Pierucci
July 1996, Clinical pharmacology and therapeutics,
G A Cinotti, and G Stirati, and F Taggi, and R Ronci, and B M Simonetti, and A Pierucci
August 1982, Experientia,
G A Cinotti, and G Stirati, and F Taggi, and R Ronci, and B M Simonetti, and A Pierucci
January 1989, Advances in experimental medicine and biology,
Copied contents to your clipboard!